Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 200 of 3959 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/22/24
End: 07/22/24
Due: 07/22/25
Phase: N/A
Priority: Normal
Start: 03/01/23
End: 03/31/24
Due: 03/31/25
Phase: N/A
Priority: Normal
Start: 06/01/25
End: 02/26/26
Due: 02/26/27
Phase: N/A
Priority: Normal
Start: 12/01/17
End: 12/31/19
Due: 12/31/20
Phase: N/A
Priority: Normal
Start: 02/01/21
End: 02/01/22
Due: 02/01/23
Phase: N/A
Priority: Normal
Start: 12/01/23
End: 03/04/24
Due: 03/04/25
Phase: N/A
Priority: Normal
Start: 03/31/15
End: 05/31/16
Due: 05/31/17
Phase: N/A
Priority: Normal
Start: 06/01/18
End: 01/31/19
Due: 01/31/20
Phase: N/A
Priority: Normal
Start: 06/22/22
End: 12/30/22
Due: 12/30/23
Phase: N/A
Priority: Normal
Start: 02/01/23
End: 07/01/23
Due: 07/01/24
Phase: N/A
Priority: Normal
Start: 06/30/25
End: 09/30/26
Due: 09/30/27
Phase: N/A
Priority: Normal
Start: 08/30/23
End: 09/14/24
Due: 09/14/25
Phase: N/A
Priority: Normal
Start: 03/31/25
End: 03/31/26
Due: 03/31/27
Phase: N/A
Priority: Normal
Start: 02/28/19
End: 10/31/19
Due: 10/31/20
Phase: N/A
Priority: Normal
Start: 01/26/21
End: 07/31/23
Due: 07/31/24
Phase: N/A
Priority: Normal
Start: 02/01/24
End: 04/30/25
Due: 04/30/26
Phase: N/A
Priority: Normal
Start: 02/28/19
End: 06/30/19
Due: 06/30/20
Phase: N/A
Priority: Normal
Start: 03/01/18
End: 06/01/18
Due: 06/01/19
Phase: N/A
Priority: Normal
Start: 07/01/24
End: 01/01/25
Due: 01/01/26
Phase: N/A
Priority: Normal
Start: 12/15/18
End: 05/15/21
Due: 05/15/22
Phase: N/A
Priority: Normal
Start: 06/30/11
End: 12/31/15
Due: 12/31/16
Phase: N/A
Priority: Normal
Start: 10/01/17
End: 01/01/19
Due: 01/01/20
Phase: N/A
Priority: Normal
Start: 08/01/25
End: 10/01/27
Due: 10/01/28
Phase: N/A
Priority: Normal
Start: 12/01/20
End: 08/01/21
Due: 08/01/22
Intravitreal Diclofenac Versus Intravitreal Ranibizumab for the Treatment of Diabetic Macular Edema.
Phase: N/A
Priority: Normal
Start: 01/31/15
End: 06/30/18
Due: 06/30/19